Jonas Manjer
161 – 170 of 353
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Determinants of non- response to a second assessment of lifestyle factors and body weight in the EPIC-PANACEA study
(
- Contribution to journal › Article
-
Mark
Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
(
- Contribution to journal › Article
-
Mark
Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study
(
- Contribution to journal › Article
-
Mark
Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
(
- Contribution to journal › Article
-
Mark
Evaluation of measurement of fat mass reduction after liposuction in obese patients.
2012) In Journal of Plastic Surgery and Hand Surgery(
- Contribution to journal › Article
-
Mark
Vasoactive Peptides with Angiogenesis-Regulating Activity Predict Cancer Risk in Males.
2012) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21(3). p.513-522(
- Contribution to journal › Article
-
Mark
Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study.
(
- Contribution to journal › Article
-
Mark
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
(
- Contribution to journal › Article
-
Mark
Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project.
(
- Contribution to journal › Article
-
Mark
Neuropeptide levels in Dercum's disease (adiposis dolorosa).
(
- Contribution to journal › Article